Abstract
The delivery of DNA to target cells using simple, defined, nonviral systems has become an area of intense interest in gene therapy. We describe here the development and characterization of one such novel system. A recombinant, bifunctional, fusion protein was expressed and purified from Escherichia coli. This protein consists of the DNA-binding domain of the yeast transcription factor GAL4 fused to the cell binding, internalization domain of the Yersinia pseudotuberculosis inv gene product, invasin. This protein, GAL4/Inv, together with poly-
Overview summary
In an effort to address the various technical and regulatory concerns associated with any gene delivery vehicle, the development of defined and easily characterized systems has taken on great significance. The ability to engineer, express, and purify recombinant proteins with specific functions represents a viable means by which to address these concerns. We describe here the generation of such a system that consists of only three parts: a single fusion protein, a DNA condensation agent, and plasmid DNA. In the specific system characterized here, the protein is a fusion between domains of GAL4 and invasin, the DNA condensation agent is poly-
Get full access to this article
View all access options for this article.
